Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
ABSTRACT
Platelet counts are tightly regulated in order to prevent thrombotic or hemorrhagic complications associated
with thrombocytosis or thrombocytopenia, respectively. While strides have been made in our understanding of
proplatelet formation (PPF), there is still limited knowledge regarding the mechanisms through which the bone
marrow (BM) extracellular matrix (ECM) regulates platelet production. Indeed, the BM includes a rich ECM with
potential to generate mechanical constraints. Yet, the impact of BM mechanics on megakaryocyte (MK)
properties and platelet formation has been understudied. Here, we propose an integrative approach to
investigate emerging concepts related to the role of MK mechanobiological receptors in controlling MK
adhesion to the ECM and platelet production. Our ultimate goal is to understand how specific MK
mechanosensors sense the BM matrix to affect the cellular cytoskeleton, MK properties and, importantly,
platelet level. Building upon our novel findings, Aim 1 explores the new paradigm and hypothesis that distinct
MK cation channels preferentially respond to different BM matrix proteins and inversely impact the MK
cytoskeleton and platelet levels. Experiments will focus on the Piezo family of cation channel mechanosensors,
as compared to the Transient Receptor Potential cation channel subfamily V member 4 mechanosensor. In
recent studies, we found these mechanosensors to have distinct preferences for different matrix proteins and
opposing effects on PPF. Investigations will be carried out using pharmacological approaches as well as newly
generated knockout mice at baseline and in response to challenges, such as myelosuppression or
thrombocytopenia. Encouraged by preliminary studies using human primary MKs, continued studies will
confirm murine findings. Aim 2 delineates mechanisms mediating novel connections between MK
mechanosensors, integrin receptors activation, cytoskeletal changes, and MK mechano-sensitive transcription
factors. This proposal is significant as there is need to identify new and alternative thrombopoietic pathways
and agents that modulate platelet counts. In addition to conceptual innovation, at the technical level we will
analyze new mouse models we developed with deletion of specific mechanosensors in MKs, and will apply
state-of-the-art imaging and measurements under flow to follow cellular processes. Proposed studies are
expected to yield new insights on the role of selective ECM sensing by MKs in controlling the MK cytoskeleton,
adhesion and platelet production, with significant potential to impact our ability to modulate platelet levels.
Public Health Relevance Statement
Narrative
Controlling platelet levels is central to management of various pathologies. Platelets develop from
megakaryocytes in a bone marrow environment, the stiffness of which varies, with potential to
generate mechanical constraints. Here, we propose an integrative approach to study specific
megakaryocyte mechanobiological receptors, such as those termed Piezo proteins (called so from the
Greek word for pressure), that sense the bone marrow matrix forces to control megakaryocyte
adhesion and platelet biogenesis.
No Sub Projects information available for 5R01HL158670-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL158670-03
Patents
No Patents information available for 5R01HL158670-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL158670-03
Clinical Studies
No Clinical Studies information available for 5R01HL158670-03
News and More
Related News Releases
No news release information available for 5R01HL158670-03
History
No Historical information available for 5R01HL158670-03
Similar Projects
No Similar Projects information available for 5R01HL158670-03